Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine Round Up 2025 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
    GST Fraud Uncovered

    GST Fraud Uncovered: Officer Among 7 Arrested in Rs 54 Crore Phony Business Scam


    Finance Outlook India Team | Tuesday, 13 August 2024

    The Delhi Government's Anti-Corruption Bureau (ACB) has identified a large Goods and Service Tax (GST) scam involving 96 fictitious firms worth Rs 54 crore, authorities said on Monday. Babita Sharma, a GST official, was one of seven people who carried out the scheme.

    Madhur Verma, Joint Commissioner of Police, ACB, stated that in addition to Sharma, three advocates: Raj Singh Saini, Narender Kumar Saini, and Mukesh Soni; two transporters; and the owner of a fictitious company were allegedly involved in the scam, which relied on the use of approximately 100 fake companies to generate fraudulent GST claims.

    These fictitious firms were utilized to fabricate invoices totaling Rs 718 crore in order to claim GST refunds. According to the investigation, these fake organizations reportedly imported and exported medical items.

    Sharma is claimed to have devised a scheme to defraud the GST administration by utilizing 96 bogus entities. Between 2021 and 2022, she granted over 400 reimbursements totaling Rs 35.51 crore. The advocates were the recipients of the reimbursement she approved. The carriers received reimbursements after providing fraudulent e-way invoices and falsified product receipts.

    How did the GST Department discover the scam?

    In September 2021, following Sharma's move to Ward 22 of the GST office, the GST Vigilance Department noticed an unexpected increase in migration requests. Within a few days, over 50 enterprises asked to shift from Ward 6 to Ward 22, and their applications were rapidly accepted, raising suspicion and prompting the government to initiate an inquiry.

    Upon a physical check of the places, the businesses were shown to be non-existent. Furthermore, the ACB discovered that Sharma approved the reimbursements without verifying the Input Tax Credit, a critical measure for detecting false claims.

    Additional inconsistencies were discovered, including the use of identical PAN numbers, email addresses, and cellphone numbers by several organizations, as well as the lack of Aadhaar validation for others.



    Read More:

    Piyush Goyal Announces Rs 10,000 Crore Fund of Funds for Startups

    Ashika Institutional, MOFSL & Bajaj Broking Markets Closing Commentary

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe About Us